119 related articles for article (PubMed ID: 1489858)
1. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
Zink A; Blind E; Raue F
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
[TBL] [Abstract][Full Text] [Related]
2. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.
Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of new assays for determination of serum calcitonin concentrations.
Weissel M; Kainz H; Tyl E; Ogunyemi E; Woloszczuk W
Acta Endocrinol (Copenh); 1991 May; 124(5):540-4. PubMed ID: 2028712
[TBL] [Abstract][Full Text] [Related]
6. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E
Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479
[TBL] [Abstract][Full Text] [Related]
7. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
9. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
10. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
Grauer A; Raue F; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of provocative tests in suspected medullary carcinoma of the thyroid:heterogeneity of calcitonin responses to calcium and pentagastrin.
McLean GW; Rabin D; Moore L; Deftos LJ; Lorber D; McKenna TJ
Metabolism; 1984 Sep; 33(9):790-6. PubMed ID: 6472115
[TBL] [Abstract][Full Text] [Related]
13. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC).
Niccoli-Sire P; Murat A; Baudin E; Henry JF; Proye C; Bigorgne JC; Bstandig B; Modigliani E; Morange S; Schlumberger M; Conte-Devolx B
Eur J Endocrinol; 1999 Nov; 141(5):468-74. PubMed ID: 10576762
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma.
Perdrisot R; Bigorgne JC; Guilloteau D; Jallet P
Clin Chem; 1990 Feb; 36(2):381-3. PubMed ID: 2302785
[TBL] [Abstract][Full Text] [Related]
15. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
16. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.
Doyle P; Düren C; Nerlich K; Verburg FA; Grelle I; Jahn H; Fassnacht M; Mäder U; Reiners C; Luster M
J Clin Endocrinol Metab; 2009 Aug; 94(8):2970-4. PubMed ID: 19491231
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method.
Emmertsen K; Marqversen J; Jensen FT; Hansen HH
Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008
[TBL] [Abstract][Full Text] [Related]
18. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
[TBL] [Abstract][Full Text] [Related]
19. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
